Search - tctmd.com

Displaying 21 - 40 of 217

Sort: Relevancy | Date

Heart Failure and Cancer: HFSA Statement Explores the Interplay

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

October 24, 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

October 04, 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

October 02, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

MicroRNA in Cardiac Transplantation: Biomarkers With Therapeutic Potential

Presentation THT 2024

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Presenter: Palak Shah

March 06, 2024

February 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

February 01, 2024

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

January 11, 2024

Who Benefits Most From Semaglutide and How Long Will That Take?

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

December 19, 2023

AI-ECG Model Outperforms STEMI Criteria for Identifying ACS Patients With Occlusions

News Daily News

AI-ECG Model Outperforms STEMI Criteria for Identifying ACS Patients With Occlusions

December 08, 2023

High-Sensitivity Troponins May Overestimate PE Severity

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

November 28, 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

November 17, 2023

November 2023 News Roundup

News Opinion CV Team Dispatch

November 2023 News Roundup

November 01, 2023

COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury

News Conference News ESC 2023

COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury

Michael O'Riordan

August 25, 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

August 25, 2023

Chest Pain, High Troponin, and Clear Coronaries: Is CMR Needed?

News Conference News SCCT 2023

Chest Pain, High Troponin, and Clear Coronaries: Is CMR Needed?

August 08, 2023

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

News Daily News

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

July 03, 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

June 29, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.